| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2796.2011.02385.X |
| P8608 | Fatcat ID | release_dcjths7n7bb57okswn7sqrq6k4 |
| P698 | PubMed publication ID | 21481018 |
| P5875 | ResearchGate publication ID | 51039891 |
| P2093 | author name string | B Jabri | |
| R Troncone | |||
| P2860 | cites work | Between celiac disease and irritable bowel syndrome: the "no man's land" of gluten sensitivity | Q24623796 |
| The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity | Q24645048 | ||
| Interleukin 18 and associated markers of T helper cell type 1 activity in coeliac disease | Q24670152 | ||
| Specificity of tissue transglutaminase explains cereal toxicity in celiac disease | Q24674073 | ||
| The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses | Q24683104 | ||
| HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease | Q28185658 | ||
| Coeliac disease | Q28242747 | ||
| Identification of tissue transglutaminase as the autoantigen of celiac disease | Q28243044 | ||
| Gluten sensitivity: from gut to brain | Q28273729 | ||
| Effect of the timing of gluten introduction on the development of celiac disease. | Q33812141 | ||
| Gluten T cell epitope targeting by TG3 and TG6; implications for dermatitis herpetiformis and gluten ataxia | Q34105229 | ||
| The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides | Q34132641 | ||
| Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues | Q34146330 | ||
| Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis | Q34325920 | ||
| Quantitation of intraepithelial lymphocytes in human jejunum | Q34474383 | ||
| Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia | Q34494273 | ||
| Psoriasis patients with antibodies to gliadin can be improved by a gluten-free diet | Q34506893 | ||
| Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome | Q34635154 | ||
| Transglutaminase autoantibodies in dermatitis herpetiformis and celiac sprue | Q34673589 | ||
| In siblings of celiac children, rectal gluten challenge reveals gluten sensitization not restricted to celiac HLA. | Q34733781 | ||
| Elevation of IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis | Q34781785 | ||
| Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase | Q35008606 | ||
| Increased prevalence of coeliac disease in diabetes | Q35118125 | ||
| Role of interferon alpha in promoting T helper cell type 1 responses in the small intestine in coeliac disease | Q35565663 | ||
| Oats induced villous atrophy in coeliac disease | Q35596070 | ||
| Concordance, disease progression, and heritability of coeliac disease in Italian twins | Q35760538 | ||
| HLA related genetic risk for coeliac disease. | Q35956063 | ||
| T cells in the pathogenesis of type 1 diabetes | Q37150506 | ||
| Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study | Q37417328 | ||
| Tissue-mediated control of immunopathology in coeliac disease | Q37638199 | ||
| NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment | Q40769893 | ||
| Clinical and pathological spectrum of coeliac disease--active, silent, latent, potential | Q40875521 | ||
| Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease | Q42606472 | ||
| A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease | Q46111066 | ||
| In vitro-deranged intestinal immune response to gliadin in type 1 diabetes. | Q47283694 | ||
| Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. | Q50793292 | ||
| A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. | Q55039025 | ||
| Interleukin 15 mediates epithelial changes in celiac disease | Q56774967 | ||
| Selective expansion of intraepithelial lymphocytes expressing the HLA-E–specific natural killer receptor CD94 in celiac disease | Q57200924 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | celiac disease | Q11088 |
| non-celiac gluten sensitivity | Q19772377 | ||
| P304 | page(s) | 582-90 | |
| P577 | publication date | 2011-06-01 | |
| P1433 | published in | Journal of Internal Medicine | Q6295387 |
| P1476 | title | Coeliac disease and gluten sensitivity | |
| P478 | volume | 269 |
| Q48452939 | Absence of somatization in non-coeliac gluten sensitivity |
| Q34480252 | Assessing of Celiac Disease and Nonceliac Gluten Sensitivity |
| Q58734569 | Autoantibodies in the Extraintestinal Manifestations of Celiac Disease |
| Q24564494 | Celiac and Non-Celiac Forms of Gluten Sensitivity: Shifting Paradigms of an Old Disease |
| Q21285138 | Celiac disease and dermatologic manifestations: many skin clue to unfold gluten-sensitive enteropathy |
| Q30234291 | Celiac disease: From pathophysiology to treatment |
| Q45722910 | Celiac disease: a disease with varied manifestations in adults and adolescents. |
| Q42635178 | Characteristics of patients who avoid wheat and/or gluten in the absence of Celiac disease |
| Q28259185 | Clinical and diagnostic aspects of gluten related disorders |
| Q37858599 | Clinical management of coeliac disease. |
| Q39106874 | Coeliac Disease in the 21st Century: No Longer "Kids' Stuff". |
| Q38025095 | Dermatitis herpetiformis: from the genetics to the development of skin lesions. |
| Q34203828 | Differentiating food allergies from food intolerances |
| Q35998352 | Distinct and Synergistic Contributions of Epithelial Stress and Adaptive Immunity to Functions of Intraepithelial Killer Cells and Active Celiac Disease |
| Q35483651 | Does gluten free diet have more implications than treatment of celiac disease? |
| Q28109448 | Fibromyalgia and non-celiac gluten sensitivity: a description with remission of fibromyalgia |
| Q35827986 | Gender differences in autoimmunity associated with exposure to environmental factors |
| Q54338854 | Gluten-dependent antibodies in horses with inflammatory small bowel disease (ISBD). |
| Q33457806 | Human leukocyte antigen genetics and clinical features of self-treated patients on a gluten-free diet |
| Q47679839 | IgA antibodies against tissue transglutaminase, endomysium and gliadin in idiopathic polyneuropathy |
| Q28083219 | Immune response to Hepatitis B vaccine in patients with celiac disease: A systematic review and meta-analysis |
| Q38783192 | Immunopathogenesis and therapeutic approaches in pediatric celiac disease |
| Q47170274 | Intestinal Production of Anti-Tissue Transglutaminase 2 Antibodies in Patients with Diagnosis Other Than Celiac Disease. |
| Q45220418 | Intestinal anti-tissue transglutaminase antibodies in potential coeliac disease. |
| Q64243435 | Long-Term Outcome of Potential Celiac Disease in Genetically at-Risk Children: The Prospective CELIPREV Cohort Study |
| Q53340078 | Measuring Biomarkers for an Innovative Personal Food Profile. |
| Q27004195 | Modern diagnosis of celiac disease and relevant differential diagnoses in the case of cereal intolerance |
| Q51067169 | Mucosal cytokine response after short-term gluten challenge in celiac disease and non-celiac gluten sensitivity. |
| Q34257275 | New understanding of gluten sensitivity |
| Q35808944 | Non-Celiac Gluten Sensitivity Has Narrowed the Spectrum of Irritable Bowel Syndrome: A Double-Blind Randomized Placebo-Controlled Trial |
| Q28307766 | Non-celiac gluten sensitivity: literature review |
| Q24567671 | Non-celiac gluten sensitivity: questions still to be answered despite increasing awareness |
| Q38156292 | Non-celiac wheat sensitivity as an allergic condition: personal experience and narrative review |
| Q34289847 | Non-celiac wheat sensitivity diagnosed by double-blind placebo-controlled challenge: exploring a new clinical entity. |
| Q89967752 | Pathogenesis of Celiac Disease and Other Gluten Related Disorders in Wheat and Strategies for Mitigating Them |
| Q34307239 | Pathophysiology of celiac disease |
| Q33605884 | Prevalence of serum celiac antibody in patients with IBD in Japan |
| Q34206293 | Rapid accumulation of CD14+CD11c+ dendritic cells in gut mucosa of celiac disease after in vivo gluten challenge |
| Q37986197 | Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers |
| Q38450842 | Seronegative celiac disease: where is the specific setting? |
| Q50084324 | The 5 Ws of a gluten challenge for gluten-related disorders |
| Q24601971 | The Oslo definitions for coeliac disease and related terms |
| Q34332412 | The dietary intake of wheat and other cereal grains and their role in inflammation |
| Q35227859 | The effects of reduced gluten barley diet on humoral and cell-mediated systemic immune responses of gluten-sensitive rhesus macaques. |
| Q47550237 | The incidence of HLA-DQ2/DQ8 in Turkish children with celiac disease and a comparison of the geographical distribution of HLA-DQ. |
| Q28077385 | The opioid effects of gluten exorphins: asymptomatic celiac disease |
| Q44749262 | Unique characteristics in Japanese dermatitis herpetiformis. |
| Q55603894 | Wheat desensitization treatment in patients with gluten sensitivity. |
| Q58597425 | Whole grain diet reduces systemic inflammation: A meta-analysis of 9 randomized trials |
Search more.